56 related articles for article (PubMed ID: 3223175)
1. Synthesis of insulin-like growth factor-II by embryonal carcinoma cell-derived differentiated cells.
Shi WK
Shi Yan Sheng Wu Xue Bao; 1988 Sep; 21(3):355-67. PubMed ID: 3223175
[No Abstract] [Full Text] [Related]
2. Production of insulin-like growth factor-II (MSA) by endoderm-like cells derived from embryonal carcinoma cells: possible mediator of embryonic cell growth.
Nagarajan L; Anderson WB; Nissley SP; Rechler MM; Jetten AM
J Cell Physiol; 1985 Aug; 124(2):199-206. PubMed ID: 4044654
[TBL] [Abstract][Full Text] [Related]
3. Possible autocrine/paracrine actions of insulin-like growth factors during embryonic development: expression and action of IGFs in undifferentiated P19 cells.
Eicher DJ; Moats-Staats BM; Stiles AD; D'Ercole AJ
Dev Genet; 1993; 14(3):194-203. PubMed ID: 8358865
[TBL] [Abstract][Full Text] [Related]
4. Effects of dietary retinoids upon growth and differentiation of tumors derived from several murine embryonal carcinoma cell lines.
McCue PA; Thomas RS; Schroeder D; Gubler ML; Sherman MI
Cancer Res; 1988 Jul; 48(13):3772-9. PubMed ID: 3378217
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-II expression in carcinoma in colon cell lines: implications for autocrine actions.
Guo YS; Jin GF; Townsend CM; Zhang T; Sheng HM; Beauchamp RD; Thompson JC
J Am Coll Surg; 1995 Aug; 181(2):145-54. PubMed ID: 7627387
[TBL] [Abstract][Full Text] [Related]
6. [Changes in patterns of protein synthesis during retinoic acid induced-differentiation of F9-1 embryonal carcinoma cells].
Liu L; Jiang YQ
Yi Chuan Xue Bao; 1988; 15(2):122-8. PubMed ID: 3273664
[No Abstract] [Full Text] [Related]
7. Potential role of IGFBPS in the regulation of the differentiation state of human colonic carcinoma cells.
Pommier G; Garrouste F; el Atiq F; Marvaldi J; Remacle-Bonnet M
Growth Regul; 1993 Mar; 3(1):80-2. PubMed ID: 7683541
[No Abstract] [Full Text] [Related]
8. IGFBP-2: an important regulator of insulin-like growth factor action in human lung tumours?
Reeve JG; Schwander J; Bleehen NM
Growth Regul; 1993 Mar; 3(1):82-4. PubMed ID: 7683542
[No Abstract] [Full Text] [Related]
9. Expression of insulin-like growth factor-II and insulin-like growth factor binding proteins during Caco-2 cell proliferation and differentiation.
Park JH; Corkins MR; Vanderhoof JA; Caruso NM; Hrbek MJ; Schaffer BS; Slentz DH; McCusker RH; MacDonald RG
J Cell Physiol; 1996 Feb; 166(2):396-406. PubMed ID: 8592000
[TBL] [Abstract][Full Text] [Related]
10. Soluble insulin-like growth factor II/mannose 6-phosphate receptor inhibits DNA synthesis in insulin-like growth factor II sensitive cells.
Scott CD; Weiss J
J Cell Physiol; 2000 Jan; 182(1):62-8. PubMed ID: 10567917
[TBL] [Abstract][Full Text] [Related]
11. Expression of insulin-like growth factor II in spontaneously immortalized rat mesothelial and spontaneous mesothelioma cells: a potential autocrine role of insulin-like growth factor II.
Rutten AA; Bermudez E; Stewart W; Everitt JI; Walker CL
Cancer Res; 1995 Aug; 55(16):3634-9. PubMed ID: 7627973
[TBL] [Abstract][Full Text] [Related]
12. Alteration of the insulin-like growth factor axis during in vitro differentiation of the human osteosarcoma cell line HOS 58.
Viereck V; Siggelkow H; Pannem R; Braulke T; Scharf JG; Kübler B
J Cell Biochem; 2007 Sep; 102(1):28-40. PubMed ID: 17372931
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor II overexpression in myoblasts induces phenotypic changes typical of the malignant phenotype.
Minniti CP; Luan D; O'Grady C; Rosenfeld RG; Oh Y; Helman LJ
Cell Growth Differ; 1995 Mar; 6(3):263-9. PubMed ID: 7794794
[TBL] [Abstract][Full Text] [Related]
14. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
Reeve JG; Morgan J; Schwander J; Bleehen NM
Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401
[TBL] [Abstract][Full Text] [Related]
15. Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro.
Andrews PW; Damjanov I; Simon D; Banting GS; Carlin C; Dracopoli NC; Føgh J
Lab Invest; 1984 Feb; 50(2):147-62. PubMed ID: 6694356
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of proliferation in human MNNG/HOS osteosarcoma and SK-ES-1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone: effects on insulin-like growth factor II.
Braczkowski R; Schally AV; Plonowski A; Varga JL; Groot K; Krupa M; Armatis P
Cancer; 2002 Oct; 95(8):1735-45. PubMed ID: 12365022
[TBL] [Abstract][Full Text] [Related]
17. Expression of insulin-like growth factor (IGF)-II and IGF-I receptor during proliferation and differentiation of CaCo-2 human colon carcinoma cells.
Zarrilli R; Pignata S; Romano M; Gravina A; Casola S; Bruni CB; Acquaviva AM
Cell Growth Differ; 1994 Oct; 5(10):1085-91. PubMed ID: 7848910
[TBL] [Abstract][Full Text] [Related]
18. Loss of imprinting of the insulin-like growth factor II gene in mouse hepatocellular carcinoma cell lines.
Ooasa T; Karasaki H; Kanda H; Nomura K; Kitagawa T; Ogawa K
Mol Carcinog; 1998 Dec; 23(4):248-53. PubMed ID: 9869454
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of insulin-like growth factor-II in mouse embryonic stem cells promotes myogenic differentiation.
Prelle K; Wobus AM; Krebs O; Blum WF; Wolf E
Biochem Biophys Res Commun; 2000 Nov; 277(3):631-8. PubMed ID: 11062005
[TBL] [Abstract][Full Text] [Related]
20. IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro.
Bendall SC; Stewart MH; Menendez P; George D; Vijayaragavan K; Werbowetski-Ogilvie T; Ramos-Mejia V; Rouleau A; Yang J; Bossé M; Lajoie G; Bhatia M
Nature; 2007 Aug; 448(7157):1015-21. PubMed ID: 17625568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
